Evaluation of the Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis

Summary

This is a 6-week, double-blind, randomized, placebo-controlled, multicenter, parallel group Phase 3 study of NAFT-600 applied once a day for 2 weeks compared to vehicle (placebo) in the treatment of tinea pedis.

Timeline

Start

2011-02

Primary completion

2011-11

Completion

2011-12

Drugs

Indications